List of articles in "Drug" category - Page 164

Preladenant (SCH 420814) was a drug that was developed by Schering-Plough which acted as a potent and selective antagonist at the adenosine A2A receptor. It was being researched as a […]

PSB-10 is a drug which acts as a selective antagonist for the adenosine A3 receptor (ki value at human A3 receptor is 0.44 nM) with high selectivity over the other […]

KF-26777 is a drug which acts as a potent and selective antagonist for the adenosine A3 receptor with sub-nanomolar affinity (A3 Ki=0.2nM) and high selectivity over the other three adenosine […]

BIBP-3226 is a drug used in scientific research which acts as a potent and selective antagonist for both the Neuropeptide Y receptor Y1 and also the neuropeptide FF receptor. It […]

BIIE-0246 is a drug used in scientific research which acts as a potent and selective antagonist for the Neuropeptide Y receptor Y2. It was one of the first non-peptide Y2-selective […]

Nirvanol also known as ethylphenylhydantoin is a derivative of hydantoin with anticonvulsant properties. Its 5-ethyl-5-phenyl substitution pattern is similar to that of phenobarbital. It is useful in the treatment of […]

Fluanisone is a typical antipsychotic and sedative of the butyrophenone chemical class. It is used in the treatment of schizophrenia and mania. U.S. Patent 2997472

Bupropion/naltrexone (proposed trade name Contrave) is an experimental treatment for obesity in phase III clinical trials. Currently being developed by Orexigen in a sustained-release formulation it is a combination of […]

Omacetaxine mepesuccinate (INN trade name Synribo) is a pharmaceutical drug that is indicated for treatment of chronic myelogenous leukemia (CML). It is a semi-synthetic derivative of the alkaloid cephalotaxine from […]

Perampanel (INN/USAN trade name Fycompa) is an antiepileptic drug developed by Eisai Co. that acts as a selective noncompetitive antagonist of AMPA receptors the major subtype of ionotropic glutamate receptors.Perampanel […]